Related Experiment Video
Updated: May 16, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Pheochromocytoma - update on disease management
Therapeutic Advances in Endocrinology and Metabolism
|November 14, 2012
Summary
Pheochromocytomas are rare, heterogeneous tumors. Understanding genetic mutations is key for personalized management, including tailored screening and surgical approaches like laparoscopic resection.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Pheochromocytomas are rare endocrine tumors often presenting insidiously.
- They are known as 'great mimics' due to diverse clinical presentations.
- These tumors are highly heterogeneous, varying by genetic mutations, age of onset, secretory profiles, and malignancy potential.
Purpose of the Study:
- To emphasize the heterogeneity of pheochromocytomas.
- To highlight the importance of considering underlying genetic mutations for optimal patient management.
- To guide optimal surgical and follow-up strategies for pheochromocytoma patients.
Main Methods:
- Review of current understanding of pheochromocytoma heterogeneity.
- Analysis of the impact of genetic mutations on tumor characteristics and management.
- Discussion of evolving surgical techniques and follow-up protocols.
Main Results:
- Pheochromocytomas are not a uniform disease but a spectrum of neoplasms.
- Genetic mutations significantly influence tumor behavior, presentation, and hereditary predisposition.
- Laparoscopic resection is the standard surgical care, with partial adrenalectomy considered for hereditary cases.
Conclusions:
- Optimal pheochromocytoma management requires individualized approaches based on genetic profiles.
- Referral to specialized centers is crucial for surgical care and long-term follow-up.
- Yearly follow-up testing and genetic screening for patients and families with mutations are essential.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...